Accès ouvert

Restraining SARS-CoV-2 in histopathology laboratory amid COVID-19 pandemic

Article scientifique 2022 Anglais

Résumé

Medical laboratory personnel encounter diverse health and workplace-related hazards leading to severe health challenges including the ravaging SARS-CoV-2 infection, which is the causal agent of COVID-19. It was first announced in Wuhan, China in December 2019 but started to spread globally by late January 2020. COVID-19 pandemic and subsequent global spreading poses additional danger to healthcare personnel particularly the laboratorians. Other health practitioners may engage patients by observing social / physical distancing, but how laboratory staff observe or apply same rule to infectious samples remain a notable question. Activities of laboratorians result in repeated exposure at close interactions to patient's samples including SARS-CoV-2 infected specimens, which make them susceptible to COVID-19. Therefore, it is imperative to review mitigating measures in restraining possible exposure and spreading of SARS-CoV-2 in the best interest of laboratory staff and pathologists. It is against this backdrop that this paper intends to update readers on measures to restrain SARS-CoV-2 invasion in histopathology laboratory and deduce precautionary measures for observation by healthcare providers in COVID-19 era. Also discussed, is health hazards associated with histopathology laboratory with the objective of encouraging safety consciousness and safe laboratory practices in the face of COVID-19 pandemic.

Citer ce document

Odigie, E., Zakariyya, A., Omorodion, N., Ogeyehme, B., Erameh, T., Shema, F., Ibrahim, D., Atanda, O., Ajayi, O., Noah, D., Mairiga, A., Idris, A., Abubakar, S., Bello, Z., Aliu, H. (2022). Restraining SARS-CoV-2 in histopathology laboratory amid COVID-19 pandemic. https://doi.org/10.3855/jidc.13894

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Statistiques

Consultations : 1

Téléchargements : 0